Breakthrough in Chronic Pain: Nervonik Completes Clinical Trial of Nerve Stimulation Technology in Panama
LOS ANGELES, Dec. 2, 2024 – In a groundbreaking development for chronic pain treatment, Nervonik, a cutting-edge medical device company, has successfully completed its first-in-human clinical trial in Panama City, Panama. This pivotal study tested Nervonik's advanced peripheral nerve stimulation (PNS) technology, designed to transform the lives of chronic pain sufferers worldwide.
Developed in the laboratory of Dr. Aydin Babakhani at the University of California, Los Angeles, Nervonik’s innovative PNS device uses proprietary technology to deliver personalized pain relief. Dr. Babakhani, the company’s CEO, celebrated the achievement: “This trial represents an exciting leap forward in our efforts to bring advanced solutions for chronic pain to the global stage.”
The feasibility study, conducted at Punta Pacifica Hospital—a Johns Hopkins-affiliated institution—involved patients with chronic shoulder and knee pain. Dr. Timothy Deer, a leading expert in neurostimulation, surgically implanted specialized micro-leads powered by a wearable device. The system, controlled via a custom app, tailored stimulation settings to each patient’s needs.
“This trial confirmed the safety and effectiveness of Nervonik’s neurotechnology, giving new hope to patients battling chronic pain,” said Dr. Deer, President and CEO of The Spine and Nerve Centers of the Virginias.
Dr. Ricardo Bermudez, principal investigator at Punta Pacifica, added: “Panama is proud to play a vital role in advancing this innovative therapy. It was truly rewarding to see patients experience significant relief.”
Nervonik’s Chief Scientific Officer, Dr. Jeff Kramer, emphasized the potential impact: “Our approach blends cutting-edge science with patient-centered care, reshaping the way chronic pain is treated.”
Detailed findings from the study are set to be presented in early 2025, positioning Panama as a key player in the future of neurotechnology-based chronic pain treatments.
SOURCE: PRNewswire
About Nervonik. Nervonik is a leading-edge medical technology company developing improved alternatives to dangerous opioid prescription and complex spinal-cord stimulators in the treatment of chronic neuropathy.
